MedTrace Logo

Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

NCT05589974 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-03-18

No results posted yet for this study

Summary

Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.

Conditions

  • Central Serous Chorioretinopathy

Interventions

DRUG

Verteporfin

Chronic CSC are receiving one treatment before the observation period.

Sponsors & Collaborators

  • Helse Stavanger HF

    lead OTHER_GOV

Principal Investigators

  • Vegard Forsaa, MD PhD · Helse Stavanger HF

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2025-12-31
Completion
2026-07-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05589974 on ClinicalTrials.gov